To determine if increased negative B cell selection, due to lowered signaling threshold of responsiveness to a ligand as a result of SHP-1 deficiency, during ontogeny leads to the origin of disease-associated IgM auto-antibodies (AAbs), 47 V H J558
Introduction
Several studies of disease-associated IgG auto-antibodies (AAbs) in systemic autoimmune disease, such as systemic lupus erythematosus (SLE), have shown that these display characteristics similar to antibodies generated in an exogenous antigen-driven immune response (1) . Few studies have focused on pathogenic AAbs of the IgM isotype, which appear before IgG AAb, and are directly capable of initiating autoimmune pathogenesis. The IgMs are also suggested to be involved in the regulation of other antibody isotypes including IgG (2, 3) and are, thus, capable of indirectly influencing AAb-mediated pathogenesis in systemic autoimmune disease. An understanding of the origin of disease-associated IgM AAbs is, therefore, an important step toward identifying the initiating biomolecule aimed at ameliorating AAb-mediated tissue damage observed in systemic autoimmune disease.
Motheaten mice homozygous for the viable recessive me v mutation develop a fatal severe SLE-like systemic autoimmune disorder and immune dysfunction (4) . The me v phenotype is linked to a loss of function (80-90%) mutation, involving thymine to adenine transversion, in the SHP-1 gene on chromosome six encoding the cytosolic tyrosine phosphatase (5-7). The SHP-1 deficiency results in severe dysregulation of hematopoietic cell development and function including increased myelopoesis. A subset of TdT + bone marrow cells are markedly depleted and prothymocytes are developmentally arrested at the pre-TdT + cell stage (6) . The SHP-1 phosphatase regulates negative selection of B lymphocytes by lowering the threshold at which these cells respond to antigen (8) (9) (10) , leading to extensive B cell deletion during ontogeny (11, 12) . The severe autoimmune disease manifested by me v /me v mice includes an over-expansion of the B-1 lymphocytes expressing CD5 (13) that virtually populate the peripheral organs and are known for the production of natural AAbs, especially of IgM isotype (14, 15) . Together with hypergammaglobulinaemia and T cell defects (16), these mice develop high titers of IgM and IgG AAbs to thymocyte (17) and doublestrand DNA (dsDNA) (13) (20) , the possible contribution of negative selection (11, 12) of B cells could not be excluded. To address the question whether increased negative B cell selection early during ontogeny leads to the origin of disease-associated IgM AAbs with restricted CDR3H size, we analyzed V H J558 + VDJCl rearrangements from 1-day-old (<24 h post-birth) autoimmune-prone me v /me v and phenotypically normal me v /+ mice. These experiments provide evidence that increased negative selection, due to enhanced responsiveness of BCR for a ligand, during B cell ontogeny does not directly lead to the emergence of disease-associated IgM AAbs but impairs the developing primary antibody repertoire.
Methods

Mice
Genetically defined homozygous (me The me v phenotype has been bred up to 33 generations on C57BL/6J background minimizing intra-strain mouse-to-mouse variation and, thus, permits the required comparative germ line repertoire analysis using a single mouse representative of the population.
PCR genotyping
Viable motheaten mice were genotyped using a PCR assay as described (22) . Briefly, genomic tail DNA was prepared by digestion with proteinase K (GIBCO-BRL) in a PCR-compatible buffer (50 mM potassium chloride, 10 mM Tris pH 8.3, 2.5 mM magnesium chloride, 0.1 mg ml ÿ1 gelatin, 0.4% v/v Nonidet P40, 0.45% v/v Tween 20, 1.5 lg ml ÿ1 proteinase K) at 55°C. The genomic DNA was PCR amplified using a set of primers specific for the SHP-1 gene in the vicinity of the T ! A transversion (me v L: 59-CGTGTCATCGTGATGACT-39; me v R: 59-AGGAAGTTGGGGCTTTGCCGT-39) in a 50-ll reaction using Taq polymerase (GIBCO-BRL). The PCR consisted of a hot start at 95°C for 1.5 min followed by 35 cycles of 94°C (denaturation) for 1.5 min, 58°C (annealing) and 72°C (extension) for 1 min each, with a final elongation step of 72°C for 7 min. The RsaI (New England Biolabs)-digested PCR product was analyzed on 6% low melting point agarose. The wild-type allele yields two products of 48 and 21 bp, while the me v allele remains undigested as indicated by a 69-bp product (22 cDNA Library RNA prepared from the spleen and liver (source of lymphopoesis in neonate) within 24 h of birth using Trizol (GIBCO-BRL) was used to synthesize cDNA using cDNA First Strand Synthesis kit (Pharmacia-Biotech). The VDJCl rearrangements were PCR amplified using the high fidelity Expand system (Boehringer-Mannheim) from cDNA using a 59 degenerate primer designed to amplify all mice V H gene families (59-AGGTCCA(A/G)CT(G/T)CTCGAGTC(A/T)GG-39) and a 39 primer located in the CH2 region of the mouse Cl gene 17) . The PCR included a hot start at 94°C and 38 cycles of denaturation at 94°C for 1.5 min, annealing at 58°C for 1.5 min and extension at 72°C for l min with a final elongation step of 72°C for 7 min. The clean PCR product (Qiaquick kit, Qiagen) was blunt ended with T4 DNA polymerase (Pharmacia-Biotech), gel purified (Qiaex II, Qiagen) and cloned into the pCR-Blunt cloning vector (Invitrogen). The ligate was used to transform TOP10 competent Escherichia coli.
Colony screening and DNA sequencing
Plasmid from bacterial colonies was initially tested for the presence of an insert by digestion with EcoRI (GIBCO-BRL). The plasmid DNA was transferred to a nylon membrane (Amersham), UV cross-linked and hybridized to either of V H J558-specific DNA probes, VNP.B4 (23) and L2M7-1v (nMeH1from this study), digoxygenin (DIG) labeled using the High Prime DIG system (Boehringer-Mannheim). The hybridization signal was detected with the chemiluminescent substrate CSPD (Boehringer-Mannheim). Known positive and negative controls were included with each Southern hybridization. The V H J558 + clones were sequenced in both directions using M13 reverse and M13 forward primers (MOBIX, McMaster University, Hamilton) and numbered according to Kabat et al. (24) . The DNA sequences can be accessed from GenBank under the accession numbers AF218628-AF218702.
DNA sequence analysis
The DNA sequences of unique VDJ recombinations, excluding duplicate isolates, were used to search for sequence similarity using the BLAST program (25) . The D H and J H genes were assigned by visual comparison to published sequences (24) (25) (26) (27) . The hydrophobicity indices were plotted according to the method of Kyte and Doolittle (28) . The pI-values for CDR3H were obtained using the web-based program (http:// www.expasy.ch/tools/pi_tool.html). The V H subfamily phylogenetic trees were compiled using MegAlign (DNAStar Inc., Madison, WI, USA).
Statistical analysis
The SAS (29) software package was used to analyze statistical differences using Fischer's exact chi-squared test. The difference in the averages of AG(C/T)/TCN (hot spot) ratios and pI were calculated using the Student's t-test. The odds ratios (OR) were calculated using GraphPad InStat version 3.05 (GraphPad Software, San Diego, CA, USA). The sophisticated logistic regression analysis of mean gene expression values was performed with S-Plus 7.0.0 (Insightful Corporation, USA) and a value <1.96 was considered significant. (Table S1; Supplementary Table S1 is available at International Immunology Online) and phenotypically normal me v /+ (Table S2; Supplementary Table S2 
Results
Individual
Increased negative selection does not directly lead to generation of disease-associated IgM AAbs
The CDR3H size of J558 + VDJCl recombinations in neonatal B cells was comparable in me v /me v (7.5 6 2.4) and me v /+ (7.0 6 2.8) mice (Fig. 3) . Variable odds either for or against selection of particular CDR size in VDJ recombinations from me v /me v and me v /+ existed with significant differences revealed by logistic regression analysis (t-value: 0.09). Nevertheless, the characteristic CDR3H size restriction (10 amino acids) noted in terminal disease state J558 + IgM AAbs (20) does not occur as a result of increased negative selection during B cell ontogeny but rather reflects the subsequent positive ligand-mediated selection in the periphery. The pI-values of CDR3H are statistically insignificant in mutant and normal mice (Tables S3 and S4; Supplementary Tables S3 and S4 are Effect of increased negative selection on neonatal IgM repertoire 665 available at International Immunology Online). Interestingly, nMeV112 recombination, encoded by V186.2 subfamily gene (Table S1; Supplementary Table S1 is available at International Immunology Online), is remarkable for a CDR3H length of nine amino acids with a net positive charge (pI: 8.59) and presence of arginine residues (Table S3; Supplementary Table S3 is available at International Immunology Online). It seems that such V186.2-expressing recombinations in B-1 and conventional B cells may possibly expand in the periphery via ligandmediated positive selection and undergo affinity maturation not via somatic hypermutation but by CDR3H size and amino acid composition based selection. An increased predisposition to hypermutations in the CDR2H region from increased negative selection in the nascent B cell repertoire is likely to facilitate generation of IgG AAbs. These observations demonstrate that increased negative selection does not directly lead to generation of disease-associated IgM AAbs during B cell ontogeny but impairs primary antibody repertoire per se.
Discussion
Susceptibility to complex systemic autoimmune diseases, such as SLE, is determined by polygenic traits (43) (20) , especially restricted CDR3H size (10 amino acids). While these observations suggested positive ligand-mediated selection of disease-associated IgM AAbs, it remained to be excluded if increased negative selection based on BCR signaling strength led to the emergence of these IgM AAbs during B cell ontogeny. Indeed, the architecture for CDR3H size and composition noted in mature B cells is already established at pre-B cell stage (44) . The experiment outlined here unequivocally demonstrate that IgM AAbs of pathogenic potential do not directly arise as a result of increased negative selection during B cell ontogeny because none of the VDJ recombinations from me v /me v mice had structural characteristics similar to those seen in IgM AAbs at terminal disease state, for example, restricted CDR3H size (20) . These observations are consistent with the fact that IgM AAbs in autoimmune mice, similar to IgG AAbs, bear structural properties similar to an induced antibody that arise via clonal selection (1, 45) with the exception of somatic hypermutations. Though, natural AAbs are also suggested to be involved in the pathogenesis of autoimmune diseases such as hemolytic anemia (46) and SLE (47) but it is uncertain as shorter CDR3H are frequently associated with polyreactivity (20, 48, 49) .
Increased negative B cell selection during ontogeny influences the composition of the pre-immune repertoire as evidenced by skewed individual V H J558 gene expression, for example, over-expression of MVAR2/10 and pM11 V H genes. It could be argued that these differences occur because of the predominance of B-1 (13) v /+ mice reflects a trend that could be attributed to escape from increased negative selection. The known bias for RF1 was noted for DSP and DFL genes expressed in both the mutant and phenotypically normal mice. A similar bias was, however, not evident for DQ genes in neonatal me v /+ B cells. The possibility of counterselection for RF2 in DQ gene, expressed at lower than expected frequencies (26, 27, 40) in me v /me v as compared with normal me v /+ mouse deserves to be investigated further as it indicates negative selection at pre-B cell level co-expressing l-heavy chain together with surrogate light chain (50) . In addition, these observations appear to be in contrast to a higher proportion of D-D fusions and D-gene inversions suggested in the MRL autoimmune-prone mouse as compared with a C3H control mouse (51) . But these seem to be due to DST gene expression rather than D-gene fusion and/or inversion events and, therefore, are not inconsistent with the observations from me v /me v mice. A trend toward differential expression of a previously unclassified J558 subfamily, designated pM11, as well as the DFL D-gene family, suggests that neonatal repertoire is skewed leading to an impaired primary antibody repertoire development as a result of increased negative selection. Such an impaired pre-immune repertoire per se provides the platform for the origin of AAb specificities of pathogenic potential by subsequent ligand-mediated positive selection in the periphery, influenced by the strength of BCR signaling (52, 53) . These observations are supported by the observed skewed V H gene expression that underlies B cell overactivity during initial stages failing to prevent emergence of autoimmunity in SLE patients (54) . This is also consistent with increased occurrence of consensus triplet (AGPy) hotspots for somatic mutation in the CDR2H region of the neonatal Ig B cell antigen receptor that provide a substrate for the production of IgG AAb of pathogenic ability. Such an enhanced mutability is reminiscent of enhanced mutation activity and abnormal selection of V H (55), Vj (56) and Vk (57) genes associated with emergence of autoimmunity in SLE patients. These observations are, however, in contrast to resistance of autoreactivity in DBA/2 B cells that display increased strength of BCR signaling following peptide immunization that leads to the development of anti-DNA antibodies in the haplotype matched BALB/c (H-2 d ) mice (52) . These differences could be attributed to differential antibody repertoire dynamics, for example, predominance of B-1 cells, involved in generation of spontaneous autoimmunity. Nevertheless, these studies are consistent with our observations that BCR signaling strength that determines increased negative B cell selection influences the germ line IgM repertoire composition such that it may predispose to the development of spontaneous or induced AAbs. Interestingly, signaling through the IgM on CD5 + B cells does not induce proliferation, but instead leads to apoptosis (58) . This process is probably mediated via SHP-1 constitutively associated with CD5 and CD72 or related CD5 ligand. CD5 is implicated in blocking the dissociation of SHP-1 from mIgM following BCR ligation (59) . As a result of SHP-1 deficiency, it is possible that CD5 fails to negatively regulate B-1 cells and permits the escape of dangerously autoreactive B-1 cells in homozygous viable motheaten mice. Analysis of antibody specificities in the neonatal and adult me ÿ/ÿ mice highlighting further complexity. This is consistent with the suggestion that phosphorylated CD5 may be responsible for abnormal BCR signaling in some but not all B-1 cell (61, 62) . Further studies involving experimental conditions that permit negative but not positive selection of B cells both centrally and peripherally will help understand the contribution of these factors to the generation of pathogenic IgM AAb. Thus, understanding relationships between negative and positive BCR signaling strength-based selection is essential to origin of disease-associated AAbs if these were an outcome of auto-antigen-driven positive selection or antigen-independent constitutive signaling (63) . Further consideration should be given to SHP-1-mediated regulation of TCR signaling strength that influences the generation of CD4 + CD25 + regulatory Tcells (64) and, also, possibly T h 2 cells.
Overall, the oultlined experiments suggest that the increased negative B cell selection, due to decreased threshold of responsiveness of BCR, for a ligand during ontogeny impairs the developing IgM antibody repertoire but does not directly lead to the generation of disease-associated IgM AAbs.
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